Cure My Disease

Don't miss your cure!

 Log in / Sign up

Smart pen tracks insulin doses to improve diabetes control

NCT ID NCT05069545

Completed Disease control Sponsor: Novo Nordisk A/S Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at whether using a smart insulin pen (NovoPen 6) with two insulins (Tresiba and Fiasp) helps people with type 1 diabetes achieve better blood sugar levels. About 411 adults took part for 9-11 months, using their own continuous glucose monitor and a mobile app to see insulin doses alongside glucose readings. The goal was to see if having this data together improves time spent in the target blood sugar range.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 1 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

type 1 diabetes mellitus type 1 diabetes mellitus 1

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DIABETES MELLITUS, TYPE 1

Contacts and locations

Locations

  • Aarhus Universitetshospital Diabetes og Hormonsygdomme

    Aarhus N, 8200, Denmark

  • Ap-Hp-Hopital Bichat-Claude Bernard-1

    Paris, 75877, France

  • Bispebjerg Hospital, IC-Forskning

    Copenhagen, 2400, Denmark

  • Centre Hospitalier Sud Francilien

    Corbeil-Essonnes, 91106, France

  • Centre Hospitalier Universitaire de Caen Normandie- Cote de Nacre

    Caen, 14033, France

  • Centre Hospitalier Universitaire de Liège

    Liège, 4000, Belgium

  • Centre Hospitalier Universitaire de Montpellier-Hopital Lapeyronie

    Montpellier, 34295, France

  • Centre Hospitalier Universitaire de Toulouse-Hopital Rangueil-2

    Toulouse, 31054, France

  • Centrum for Diabetes, Academical Specialist Centrum

    Stockholm, 113 65, Sweden

  • Chru de Nancy - Hopital Brabois

    Vandœuvre-lès-Nancy, 54511, France

  • Cliniques Universitaires Saint-Luc - Serv Endocrinologie - Diabétologie

    Brussels, 1200, Belgium

  • Diabetesmottagningen, Medicinkliniken, Södra Älvsborgs Sjukhus

    Borås, 501 82, Sweden

  • Diabetesmottagningen, Södra Älvsborgs Sjukhus

    Borås, 501 82, Sweden

  • Endokrinologiska kliniken, Malmö

    Malmö, 205 02, Sweden

  • Frölunda Specialistsjukhus

    Västra Frölunda, 42144, Sweden

  • HUB - Hôpital Erasme

    Brussels, 1070, Belgium

  • Hospices Civils de Lyon-Hopital Lyon Sud-2

    Pierre-Bénite, 69495, France

  • Imeldaziekenhuis - Bonheiden - Department of Endocrinology

    Bonheiden, 2820, Belgium

  • Medicinkliniken Sundsv

    Sundsvall, 851 86, Sweden

  • Medicinmottagning1 Universitetssjukhuset Örebro

    Örebro, 701 85, Sweden

  • Medicinsk Afdeling B, Herning Centralsygehus

    Herning, 7400, Denmark

  • Regionshospitalet Silkeborg - Endokrinologisk afd.

    Silkeborg, 8600, Denmark

  • UZ Leuven - Endocrinology

    Leuven, 3000, Belgium

  • UZA - UZ Antwerpen - Department of Endocrinology

    Edegem, 2650, Belgium

  • Uppsala universitetssjukhus

    Uppsala, 751 85, Sweden

  • hôpital Saint Joseph Saint Luc

    Lyon, 69365, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.